000 | 01815 a2200565 4500 | ||
---|---|---|---|
005 | 20250516080410.0 | ||
264 | 0 | _c20120629 | |
008 | 201206s 0 0 eng d | ||
022 | _a1873-2933 | ||
024 | 7 |
_a10.1016/j.clinbiochem.2012.01.028 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRababah, Munir | |
245 | 0 | 0 |
_aAnticoagulants affect matrix metalloproteinase 9 levels in blood samples of stroke patients and healthy controls. _h[electronic resource] |
260 |
_bClinical biochemistry _cApr 2012 |
||
300 |
_a483-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAnticoagulants _xpharmacology |
650 | 0 | 4 | _aArtifacts |
650 | 0 | 4 |
_aBlood Chemical Analysis _xmethods |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 |
_aCitric Acid _xpharmacology |
650 | 0 | 4 | _aEnzyme Stability |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHeparin _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukocytes, Mononuclear _xenzymology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMatrix Metalloproteinase 9 _xblood |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
650 | 0 | 4 | _aStatistics, Nonparametric |
650 | 0 | 4 |
_aStroke _xblood |
650 | 0 | 4 | _aTranscription, Genetic |
700 | 1 | _aWorthmann, Hans | |
700 | 1 | _aDeb, Milani | |
700 | 1 | _aTryc, Anita B | |
700 | 1 | _aMa, Yue Tao | |
700 | 1 | _aEl Bendary, Omnia M | |
700 | 1 | _aHecker, Hartmut | |
700 | 1 | _aGoldbecker, Annemarie | |
700 | 1 | _aHeeren, Meike | |
700 | 1 | _aBrand, Korbinian | |
700 | 1 | _aWeissenborn, Karin | |
700 | 1 | _aLichtinghagen, Ralf | |
773 | 0 |
_tClinical biochemistry _gvol. 45 _gno. 6 _gp. 483-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clinbiochem.2012.01.028 _zAvailable from publisher's website |
999 |
_c21552722 _d21552722 |